(Q44882404)

7 December 2017

title

N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin (English)

1 reference

7 December 2017

0 references

K Bartmann

1

1 reference

7 December 2017

R Tarbuc

series ordinal

2

1 reference

7 December 2017

language of work or name

German

0 references

publication date

1 November 1982

1 reference

7 December 2017

number of pages

10

1 reference

inferred from page(s)

published in

Infection

1 reference

7 December 2017

volume

10

1 reference

7 December 2017

issue

6

1 reference

7 December 2017

page(s)

361-370

1 reference

In vitro evaluation of cefoperazone

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

In Vitro Activity of Piperacillin Compared with That of Carbenicillin, Ticarcillin, Ampicillin, Cephalothin, and Cefamandole Against Pseudomonas aeruginosa and Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

In vitro activity of thienamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

In Vitro Activity of LY127935

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Clinical evaluation of moxalactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

In vitro studies of piperacilin, a new semisynthetic penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

In vitro evaluation of Ro 13-9904

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Antimicrobial activity of cefmenoxime (SCE-1365).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Comparison of the Activities of the New Ureidopenicillins Piperacillin, Mezlocillin, Azlocillin, and Bay k 4999 Against Gram-Negative Organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

In Vitro Activity of Furazlocillin (Bay k 4999) Compared with Those of Mezlocillin, Piperacillin, and Standard Beta-Lactam Antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Comparative in vitro study in new cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01642300

Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum

21 January 2018

1 reference

12 December 2020

Comparison of activity and beta-lactamase stability of cefotaxime with those of six other cephalosporins

1 reference

12 December 2020

Azlocillin: comparison of in vitro antibacterial activity with carbenicillin and evaluation of regression lines for sensitivity testing by the standard agar diffusion method

1 reference

12 December 2020

In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs

1 reference

12 December 2020

Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new).

1 reference

12 December 2020

Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin

1 reference

12 December 2020

Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates

1 reference

12 December 2020

In vitro studies of 1-oxacephalosporin (LY 127935), a new beta-lactam antibiotic

1 reference

12 December 2020

In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime

1 reference

12 December 2020

[Bacteriological investigations with a new Semisynthetic oxy-beta-lactam antibiotic LY 127935 (AUTHOR'S TRANSL)]

1 reference

12 December 2020

In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin

1 reference

12 December 2020

Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli

1 reference

12 December 2020

Studies on the antibacterial activity of two new acylureidopenicillins, mezlocillin and azlocillin

1 reference

12 December 2020

In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp

1 reference

12 December 2020

GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae

1 reference

12 December 2020

Azlocillin and mezlocillin, two new alpha-amino-substituted penicillins. A comparison of the in vitro activity with other penicillins

1 reference

12 December 2020

MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities

1 reference

12 December 2020

In vitro and in vivo antibacterial activity of cefoperazone

1 reference

12 December 2020

Piperacillin, a new penicillin active against many bacteria resistant to other penicillins

1 reference

12 December 2020

Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa

1 reference

12 December 2020

In vitro antimicrobial activity of cefotaxime, a new cephalosporin

1 reference

12 December 2020

Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.

1 reference

12 December 2020

Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties

1 reference

12 December 2020

In Vitro Comparison of N -Formimidoyl Thienamycin, Piperacillin, Cefotaxime, and Cefoperazone

1 reference

12 December 2020

Antibacterial activity of mezlocillin and azlocillin/A survey (author's transl)

1 reference

12 December 2020

N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics

1 reference

12 December 2020

In vitro and in vivo microbiological evaluations of cefoperazone.

1 reference

12 December 2020

Inhibitory concentrations of cefoperazone, cefazolin, cefamandole, cephaloridine, and cefoxitin for 300 gram-negative clinical isolates

1 reference

12 December 2020

[Investigation on the antimicrobial activity of cefoperazone (author's transl)]

1 reference

12 December 2020

Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics

1 reference

12 December 2020

Azlocillin--a new penicillin against Pseudomonas aeruginosa and other gram-negative bacteria

1 reference

12 December 2020

Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi

1 reference

12 December 2020

In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli

1 reference

12 December 2020

A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics

1 reference

12 December 2020

In vitro activity of N-formimidoyl thienamycin (MK0787).

1 reference

12 December 2020

In vitro activity of a new semisynthetic cephalosporin: cefoperazone.

1 reference

12 December 2020

N-formimidoyl thienamycin (MK0787): in vitro study

1 reference

12 December 2020

Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa

1 reference

12 December 2020

Cefoperazone: evaluation of the in vitro activity and an analysis of the disk diffusion test

1 reference

12 December 2020

In vitro antibacterial activity of moxalactam, a new broad-spectrum semisynthetic antibiotic.

1 reference

12 December 2020

In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.

1 reference

12 December 2020

Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853

1 reference

12 December 2020

Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters

1 reference

12 December 2020

[Bacteriological studies in vitro on cefsulodin, a new cephalosporin active against Pseudomonas (author's transl)]

1 reference

12 December 2020

Comparative Activities of the Oxa-β-Lactam LY127935, Cefotaxime, Cefoperazone, Cefamandole, and Ticarcillin Against Multiply Resistant Gram-Negative Bacilli

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01642300

1 reference

7 December 2017

1 reference